Yuliang Zhao

702 total citations
11 papers, 623 citations indexed

About

Yuliang Zhao is a scholar working on Molecular Biology, Biomedical Engineering and Materials Chemistry. According to data from OpenAlex, Yuliang Zhao has authored 11 papers receiving a total of 623 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Biomedical Engineering and 5 papers in Materials Chemistry. Recurrent topics in Yuliang Zhao's work include Nanoplatforms for cancer theranostics (3 papers), Nanoparticle-Based Drug Delivery (2 papers) and Luminescence Properties of Advanced Materials (2 papers). Yuliang Zhao is often cited by papers focused on Nanoplatforms for cancer theranostics (3 papers), Nanoparticle-Based Drug Delivery (2 papers) and Luminescence Properties of Advanced Materials (2 papers). Yuliang Zhao collaborates with scholars based in China, Luxembourg and United States. Yuliang Zhao's co-authors include Zhanjun Gu, Shuang Zhu, Zhao Guo, Jiangfeng Du, Xinghua Dong, Jiani Xie, Xiao Zhang, Qing Wang, Yuan Yong and Zhen Du and has published in prestigious journals such as Chemical Society Reviews, Advanced Materials and Advanced Functional Materials.

In The Last Decade

Yuliang Zhao

9 papers receiving 617 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuliang Zhao China 7 488 331 135 123 114 11 623
Yujie Li China 11 465 1.0× 372 1.1× 125 0.9× 133 1.1× 84 0.7× 18 650
Renlu Han China 16 388 0.8× 342 1.0× 123 0.9× 89 0.7× 81 0.7× 34 574
Weiqiang Ge China 5 636 1.3× 454 1.4× 169 1.3× 121 1.0× 144 1.3× 9 771
Quanwei Guo China 14 405 0.8× 358 1.1× 138 1.0× 173 1.4× 55 0.5× 27 708
Zhengping Cheng China 4 455 0.9× 306 0.9× 112 0.8× 105 0.9× 115 1.0× 7 575
Zengxia Zhao China 9 374 0.8× 367 1.1× 101 0.7× 78 0.6× 134 1.2× 13 531
Jeong Chan Park South Korea 12 282 0.6× 261 0.8× 215 1.6× 124 1.0× 56 0.5× 23 661
Xinhong He China 7 509 1.0× 395 1.2× 191 1.4× 88 0.7× 103 0.9× 10 626
Huandong Xiang China 9 334 0.7× 351 1.1× 55 0.4× 125 1.0× 44 0.4× 10 525
Tongxu Gu China 10 412 0.8× 300 0.9× 132 1.0× 154 1.3× 53 0.5× 17 554

Countries citing papers authored by Yuliang Zhao

Since Specialization
Citations

This map shows the geographic impact of Yuliang Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuliang Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuliang Zhao more than expected).

Fields of papers citing papers by Yuliang Zhao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuliang Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuliang Zhao. The network helps show where Yuliang Zhao may publish in the future.

Co-authorship network of co-authors of Yuliang Zhao

This figure shows the co-authorship network connecting the top 25 collaborators of Yuliang Zhao. A scholar is included among the top collaborators of Yuliang Zhao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuliang Zhao. Yuliang Zhao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Xu, Zhuo, Zhongmin Jin, Suping Li, et al.. (2025). Silico-driven drug discovery: A paradigm shift for nanomedicine science and industry. Nano Today. 66. 102918–102918.
2.
Song, Xiaolin, Xinke Zhang, Hu‐Jun Qian, et al.. (2025). In Silico Methods, Simulations, and Design of Drug‐Delivery Nanocarriers. Advanced Functional Materials. 36(23).
3.
Zheng, Jia‐Jia, et al.. (2024). Computer-aided nanodrug discovery: recent progress and future prospects. Chemical Society Reviews. 53(18). 9059–9132. 19 indexed citations
4.
Wang, Lixuan, Jing Hu, Kun Li, Yuliang Zhao, & Motao Zhu. (2024). Advancements in gene editing technologies for probiotic-enabled disease therapy. iScience. 27(9). 110791–110791. 13 indexed citations
5.
Zhang, Aiying, et al.. (2023). [Analysis of continuous polysomnography in children with recurrent vertigo].. PubMed. 37(4). 258–262. 1 indexed citations
6.
Wang, Shuyu, et al.. (2022). A Hydrogel-Based Self-Sensing Underwater Actuator. SSRN Electronic Journal. 1 indexed citations
7.
Wang, Xin, Zhao Guo, Chenyang Zhang, et al.. (2020). Ultrasmall BiOI Quantum Dots with Efficient Renal Clearance for Enhanced Radiotherapy of Cancer. Advanced Science. 7(6). 1902561–1902561. 91 indexed citations
8.
Li, Jinxia, Haoran Su, Liang Yan, et al.. (2019). The pharmaceutical multi-activity of metallofullerenol invigorates cancer therapy. Nanoscale. 11(31). 14528–14539. 20 indexed citations
9.
Du, Zhen, Xiao Zhang, Zhao Guo, et al.. (2018). X‐Ray‐Controlled Generation of Peroxynitrite Based on Nanosized LiLuF4:Ce3+ Scintillators and their Applications for Radiosensitization. Advanced Materials. 30(43). e1804046–e1804046. 177 indexed citations
11.
Li, Jinxia & Yuliang Zhao. (2015). Nanotechnology in the programmed cell therapy: nowhere to escape of cancer. Science Bulletin. 61(1). 45–47. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026